QHSLab, Inc. (USAQ) Fair Value 2026

USAQ · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.2 /10

32 fundamental signals · 9 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-08-27, QHSLab, Inc. (USAQ) trades at $0.33, versus a $0.55 median fair value across its 9 active models — 69.3% above the current price. QOC: 8.2/10. Value Trap Risk: 18/100 (SAFE). 9/13 models active. Within that set, the Bayesian DCF component alone returns $0.61.

Key Facts

Ticker
USAQ
Price
$0.33
Quality Score
8.2/10
Value Trap Risk
18/100
Models Active
9/13
Last Updated
Strength: ML-RIV suggests +146.3% upside with 51% confidence
Risk: Limited model coverage (9/13) may reduce confidence

Is QHSLab, Inc. (USAQ) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, QHSLab, Inc. (USAQ) appears undervalued as of : the median of 9 independent fair value estimates is $0.55, 69.3% above the current price of $0.33. Estimates range from $0.30 to $0.80. USAQ scores 8.2/10 on fundamental quality and 18/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. USAQ’s +69.3% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy QHSLab, Inc. Stock in 2026? →

What Fair Value Does Each Model Give USAQ?

9 Intrinsic Value Models vs. Current Price ($0.33)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.61 +86.9%
Ensemble · Medium Conviction
 $0.55 +69.3%
Scenario · High Conviction
 $0.51 +55.7%
Intrinsic · High Conviction
 $0.80 +146.3%
Unlock the Full Matrix

Access 5 additional models including Markov DDM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is USAQ's Fair Value Range?

Spread across 9 independent models · $0.30 to $0.80

CirclFi's 9 active models place QHSLab, Inc. (USAQ) between $0.30 and $0.80 per share, a spread of 91% of the median. The median of that range — $0.55 — is the fair value CirclFi publishes for USAQ, against a current price of $0.33.

Low · RCMH-DCFHigh · Markov DDM
$0.30median $0.55$0.80
Where the range comes from
Most bearish modelRCMH-DCF$0.30
Most bullish modelMarkov DDM$0.80
Model agreement7 bullish · 1 bearishmoderate

A band of this width is typical. The methods agree on direction but weight growth, reinvestment and risk differently, so treat the median as a centre of gravity rather than a precise target.

Every figure above is one model's standalone output on USAQ, not a CirclFi price target. How each model works →

What Is QHSLab, Inc. (USAQ) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, QHSLab, Inc. is potentially undervalued at its current price of $0.33. Based on our 13-model framework, QHSLab, Inc.'s intrinsic value is estimated at a median fair value of $0.55 — representing +69.3% implied upside — with 7 out of 9 active models confirming this thesis. Model dispersion is worth noting: Markov DDM targets $0.80 (+146.6%), versus RCMH-DCF at $0.30 (-8.1%). This +154.6% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About USAQ?

9 of 13 models are currently active for USAQ. Of these, 7 models suggest upside while 2 models suggest overvaluation. Taken together, their median fair value for USAQ is $0.55 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $0.61 on its own, implying +86.9% upside from the current price. See which stocks rank higher →

How Does USAQ Rank in Medical Devices?

Among 157 Medical Devices stocks, USAQ ranks #22 by Quality of Company score. CirclFi's QOC score of 8.2/10 evaluates 32 fundamental signals. A score of 8.2 places USAQ in the top tier.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to biopharma enterprise businesses. For QHSLab, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is USAQ a Value Trap?

CirclFi's Value Trap algorithm assigns USAQ a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for QHSLab, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, QHSLab, Inc. scores 8.2 out of 10 on our 32-signal quality assessment, a strong rating that demonstrates strong fundamentals across the majority of our quality signals. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +154.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every USAQ valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across USAQ's 9 active models, average confidence is 41%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy QHSLab, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

HAEHaemonetics CorporationQOC 8.3MDNCMedinotec Inc.QOC 8.2ZBHZimmer Biomet Holdings, Inc.QOC 8.4BVSBioventus Inc.QOC 8.2XTNTXtant Medical Holdings, Inc.QOC 8.4ITGRInteger Holdings CorporationQOC 8.2RCELAVITA Medical, Inc.QOC 6.7VNRXVolitionRx LimitedQOC 5.7ADGMAdagio Medical Holdings, Inc.QOC 4.3IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: HAE · MDNC · ZBH · BVS · XTNT · ITGR · RCEL · VNRX · ADGM · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to USAQ?

7 companies across all industries closest to USAQ’s Quality of Company score of 8.2/10.

LKFNLakeland Financial CorporationQOC 8.3FRAFFranklin Financial Services CorporationQOC 8.2ZIONZions Bancorporation, National AssociationQOC 8.3RHPRyman Hospitality Properties, Inc.QOC 8.2LEUCentrus Energy Corp.QOC 8.3CCBCoastal Financial CorporationQOC 8.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LKFN · FRAF · ZION · RHP · LEU · CCB · NVDA

Where Does USAQ Sit in CirclFi's Medical Devices Rankings?

USAQ is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About QHSLab, Inc.’s Valuation?

What is QHSLab, Inc.'s intrinsic value in 2026?

CirclFi puts QHSLab, Inc. (USAQ)'s intrinsic value at $0.55 — the median of 9 independent model estimates as of 2026-08-27, ranging from $0.30 to $0.80. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $0.61 on its own. The Quality of Company score is 8.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is USAQ overvalued or undervalued right now?

At $0.33, 7 of 9 active models suggest USAQ may be undervalued, while 2 indicate potential overvaluation. The median of all 9 fair value estimates is $0.55, 69.3% above the current price of $0.33 — a consensus view that USAQ is undervalued. The assessment depends on which methodology best fits QHSLab, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 8.2 mean for USAQ?

QHSLab, Inc.'s QOC of 8.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on USAQ?

CirclFi analyzes USAQ with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on USAQ?

Of the 9 models currently active on USAQ, Markov DDM is the most bullish at $0.80 per share, and RCMH-DCF is the most bearish at $0.30. CirclFi's published fair value for USAQ is the median of that range, $0.55, not either extreme. The gap between the two ends equals 91% of the median — a normal spread for a company of this profile. Browse stocks by value-trap risk →

Is USAQ a value trap in 2026?

QHSLab, Inc.'s Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, QHSLab, Inc. (USAQ) has a median fair value of $0.55 — 69.3% above the current price of $0.33 — as of 2026-08-27.” Source: circlfi.com/stock/USAQ/ · Methodology
Primary sources for this USAQ valuation
  • Financial statements: QHSLab, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000856984) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for USAQ as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on USAQ.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for USAQ Unlock All 9 — $39/mo